Research
Hormonal
Semaglutide (2.4 mg once weekly) resulted in weight loss of up to 13.9% after 68 weeks.
Semaglutide is a viable weight loss treatment for adults without diabetes.
StrongSupportsmedium confidence
semaglutide (2.4 mg once weekly), up to 13.9% (CI, 11.0% to 16.7%) after 68 weeks.
Why this rating
The study is based on randomized controlled trials.
Source
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
Areesha Moiz et al. · Annals of Internal Medicine · 2025
rctCited 108×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →